The Joint Corp. (JYNT)
USD 10.5
(1.5%)
USD 10.5
(1.5%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 117.69 Million USD | 15.49% |
| 2022 | 101.91 Million USD | 25.52% |
| 2021 | 81.19 Million USD | 38.36% |
| 2020 | 58.68 Million USD | 21.12% |
| 2019 | 48.45 Million USD | 52.41% |
| 2018 | 31.78 Million USD | 26.33% |
| 2017 | 25.16 Million USD | 22.61% |
| 2016 | 20.52 Million USD | 48.34% |
| 2015 | 13.83 Million USD | 94.41% |
| 2014 | 7.11 Million USD | 19.45% |
| 2013 | 5.95 Million USD | 113.94% |
| 2012 | 2.78 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 30.26 Million USD | 1.81% |
| 2024 Q1 | 29.72 Million USD | -2.91% |
| 2023 FY | 117.69 Million USD | 15.49% |
| 2023 Q3 | 29.47 Million USD | 0.57% |
| 2023 Q4 | 30.61 Million USD | 3.87% |
| 2023 Q1 | 28.45 Million USD | 2.29% |
| 2023 Q2 | 29.3 Million USD | 3.01% |
| 2022 Q4 | 27.81 Million USD | 5.15% |
| 2022 Q1 | 22.43 Million USD | 0.02% |
| 2022 Q2 | 25.05 Million USD | 11.67% |
| 2022 Q3 | 26.44 Million USD | 5.56% |
| 2022 FY | 101.91 Million USD | 25.52% |
| 2021 Q1 | 17.54 Million USD | 2.99% |
| 2021 FY | 81.19 Million USD | 38.36% |
| 2021 Q2 | 20.21 Million USD | 15.22% |
| 2021 Q3 | 20.99 Million USD | 3.82% |
| 2021 Q4 | 22.43 Million USD | 6.87% |
| 2020 Q1 | 13.64 Million USD | -1.66% |
| 2020 Q2 | 12.58 Million USD | -7.73% |
| 2020 Q3 | 15.41 Million USD | 22.41% |
| 2020 FY | 58.68 Million USD | 21.12% |
| 2020 Q4 | 17.03 Million USD | 10.56% |
| 2019 Q4 | 13.87 Million USD | 9.03% |
| 2019 Q2 | 11.16 Million USD | 4.59% |
| 2019 Q1 | 10.67 Million USD | 17.72% |
| 2019 FY | 48.45 Million USD | 52.41% |
| 2019 Q3 | 12.72 Million USD | 13.93% |
| 2018 Q3 | 8.06 Million USD | 6.69% |
| 2018 FY | 31.78 Million USD | 26.33% |
| 2018 Q4 | 9.07 Million USD | 12.52% |
| 2018 Q2 | 7.55 Million USD | 6.47% |
| 2018 Q1 | 7.09 Million USD | 2.43% |
| 2017 Q1 | 5.67 Million USD | -1.85% |
| 2017 FY | 25.16 Million USD | 22.61% |
| 2017 Q4 | 6.92 Million USD | 5.86% |
| 2017 Q3 | 6.54 Million USD | 8.83% |
| 2017 Q2 | 6.01 Million USD | 6.01% |
| 2016 Q1 | 4.26 Million USD | 13.35% |
| 2016 FY | 20.52 Million USD | 48.34% |
| 2016 Q4 | 5.78 Million USD | 5.04% |
| 2016 Q3 | 5.5 Million USD | 10.65% |
| 2016 Q2 | 4.97 Million USD | 16.62% |
| 2015 Q1 | 2.5 Million USD | 22.02% |
| 2015 Q3 | 4.13 Million USD | 20.76% |
| 2015 Q2 | 3.42 Million USD | 36.64% |
| 2015 Q4 | 3.76 Million USD | -9.07% |
| 2015 FY | 13.83 Million USD | 94.41% |
| 2014 FY | 7.11 Million USD | 19.45% |
| 2014 Q1 | 1.51 Million USD | -8.45% |
| 2014 Q4 | 2.05 Million USD | 13.15% |
| 2014 Q2 | 1.73 Million USD | 14.48% |
| 2014 Q3 | 1.81 Million USD | 4.89% |
| 2013 Q3 | 1.47 Million USD | 0.0% |
| 2013 Q4 | 1.65 Million USD | 12.2% |
| 2013 FY | 5.95 Million USD | 113.94% |
| 2012 FY | 2.78 Million USD | 0.0% |
| 2001 Q3 | 20.99 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.92 Billion USD | 95.981% |
| Addus HomeCare Corporation | 1.05 Billion USD | 88.882% |
| AirSculpt Technologies, Inc. | 195.91 Million USD | 39.925% |
| Amedisys, Inc. | 2.23 Billion USD | 94.737% |
| Astrana Health, Inc. | 1.38 Billion USD | 91.512% |
| Aveanna Healthcare Holdings Inc. | 1.89 Billion USD | 93.79% |
| IMAC Holdings, Inc. | 5.19 Million USD | -2164.698% |
| biote Corp. | 185.36 Million USD | 36.504% |
| Cryo-Cell International, Inc. | 31.34 Million USD | -275.502% |
| Cross Country Healthcare, Inc. | 2.01 Billion USD | 94.173% |
| COMPASS Pathways plc | - USD | -Infinity% |
| DocGo Inc. | 624.28 Million USD | 81.147% |
| The Ensign Group, Inc. | 3.72 Billion USD | 96.844% |
| Healthcare Services Group, Inc. | 1.67 Billion USD | 92.958% |
| InnovAge Holding Corp. | 763.85 Million USD | 84.592% |
| LifeStance Health Group, Inc. | 1.05 Billion USD | 88.851% |
| Mobile-health Network Solutions Class A Ordinary Shares | 10.35 Million USD | -1036.228% |
| ModivCare Inc. | 2.75 Billion USD | 95.722% |
| NewGenIvf Group Limited | 5.13 Million USD | -2191.527% |
| Option Care Health, Inc. | 4.3 Billion USD | 97.264% |
| P3 Health Partners Inc. | 1.26 Billion USD | 90.706% |
| P3 Health Partners Inc. | 1.26 Billion USD | 90.706% |
| The Pennant Group, Inc. | 544.89 Million USD | 78.4% |
| Surgery Partners, Inc. | 2.74 Billion USD | 95.71% |
| Syra Health Corp. Class A Common Stock | 5.51 Million USD | -2034.058% |
| Talkspace, Inc. | 150.04 Million USD | 21.559% |
| Talkspace, Inc. | 150.04 Million USD | 21.559% |
| The Oncology Institute, Inc. | 324.23 Million USD | 63.701% |
| The Oncology Institute, Inc. | 324.23 Million USD | 63.701% |